Wengui Shi

8PUBLICATIONS
45CO-AUTHORS
Medical infection agents (incl. prions)Cancer diagnosisCancer cell biologyChemotherapyTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 04, 2026
Midbody Remnants as Signaling Centers in Cell Fate Determination and Tumorigenesis.

|Nov 06, 2025
USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Coevolution in Pancreatic Cancer.

Xiangyan Jiang, Bin Zhao, Tao Wang

|Sep 23, 2024
Targeting SHCBP1 Inhibits Tumor Progression by Restoring Ciliogenesis in Ductal Carcinoma.

Wengui Shi, Lianshun Li, Huiming Zhao

|Jan 12, 2024
SHCBP1 Overexpression Aggravates Pancreatitis by Triggering the Loss of Primary Cilia.

Lianshun Li, Huiming Zhao, Zhengyang Li

|Aug 30, 2023
PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric Cancer.

Huili Ye, Wengui Shi, Jing Yang

|Jul 20, 2022
Reveal the Mechanisms of Yi-Fei-Jian-Pi-Tang on Covid-19 through Network Pharmacology Approach.

Wanying Lang, Feng Yang, Fanfan Cai

Pageof 2

Frequent Collaborators

5 joint publications

Zuoyi Jiao

4 joint publications

Long Qin

4 joint publications

Huinian Zhou

3 joint publications

Zeyuan Yu